SBIR/STTR Reauthorization: CEOs and Innovation Leaders Urging Prompt Action from Congress to Protect US Innovation
The lapse in authorization for the federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs is taking a devastating toll on America’s most innovative small businesses—stalling research, halting commercialization efforts, and putting our competitive edge at risk. These programs are vital engines of discovery that have powered U.S. leadership in technology, healthcare, defense, and clean energy for more than four decades.
EGC is leading a national effort to raise Congressional awareness of the detrimental impacts of the lapse in SBIR/STTR funding, and to urgently advocate for the reauthorization of these critical programs. We are grateful for many companies who have co-signed our Letter to Congress, and we encourage everyone in the innovation community to continue to spread the word by reaching out to your representatives and sharing this information with your networks to motivate congressional action by the end of January 2026.
1300+ small business leaders have signed our letter to Congress!
The letter was sent on January 15 along with 400+ case studies of impacted entrepreneurs (see press release). Our collective voices are making the message clear to Congress: it is critical to take action now!
Section 174 Innovation Tax Repealed — Thank You for Making It Happen!
We’re thrilled to share the incredible news: the Section 174 “Innovation Tax” has been repealed! This victory is a testament to the dedication, collaboration, and persistence of innovators, entrepreneurs, advocates, and organizations across the country who came together to protect U.S. research and development.